Profilo
Suhail Nurbhai has been Vice President of Clinical Development for Dynogen Pharmaceuticals, Inc. since June 2005.
Prior to joining Dynogen Pharmaceuticals, he was an Executive Director and Head of CNS Clinical Research and Development for Pfizer, Inc. from 1993 to 2005.
Previously, Dr. Nurbhai worked for the Gastroenterology Department of Broad Green Hospital.
He was a Member of the Royal College of Physicians for the United Kingdom.
Dr. Nurbhai received a degree in Medicine from Dundee University in Scotland and a Master degree in General Medical Training from the University of Manchester.
Precedenti posizioni note di Suhail Nurbhai
| Società | Posizione | Fine |
|---|---|---|
Dynogen Pharmaceuticals, Inc.
 Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynogen Pharmaceuticals, Inc. develops and manufactures drugs. The company makes drugs for genitourinary and gastrointestinal disorders. It also makes drugs for constipation, Irritable Bowel Syndrome and overactive bladder. Dynogen Pharmaceuticals was founded by Lee R. Brettman in 2002 and is located in Waltham, MA. | Corporate Officer/Principal | 13/11/2009 |
| PFIZER, INC. | Chief Tech/Sci/R&D Officer | 01/01/2005 |
| The Royal College of Physicians | Corporate Officer/Principal | - |
Formazione di Suhail Nurbhai
| The University of Manchester | Graduate Degree |
| University Of Dundee | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Dynogen Pharmaceuticals, Inc.
Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dynogen Pharmaceuticals, Inc. develops and manufactures drugs. The company makes drugs for genitourinary and gastrointestinal disorders. It also makes drugs for constipation, Irritable Bowel Syndrome and overactive bladder. Dynogen Pharmaceuticals was founded by Lee R. Brettman in 2002 and is located in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Suhail Nurbhai
